3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
12
Neoplasm Metastasis
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Salivary Gland Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm, Residual
1
Mouth Neoplasms
1
Melanoma
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
HER2-positive Gastric Cancer
1
HER2-positive Breast Cancer
1
HER2-positive Advanced Gastric Cancer
1
HER2 Overexpression
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Interventions
Surveys and Questionnaires
26
Blood Specimen Collection
19
Radiotherapy
17
Gene Expression Profiling
11
Immunohistochemistry
9
Cetuximab
6
Polymerase Chain Reaction
5
Nivolumab
5
Immunotherapy
5
Cisplatin
5
Microarray Analysis
4
Drug Therapy
4
Biopsy
4
pembrolizumab
3
Tissue Banks
3
Therapeutics
3
Reverse Transcriptase Polymerase Chain Reaction
3
Restraint, Physical
3
Radiotherapy, Intensity-Modulated
3
Radiation
3
Observation
3
Interviews as Topic
3
Immunologic Techniques
3
Immunoenzyme Techniques
3
Flow Cytometry
3
Chemotherapy, Adjuvant
3
Surgical Procedures, Operative
2
Quality of Life
2
Psychiatric Rehabilitation
2
Physical Therapy Modalities
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Head and Neck Neoplasms
×
trastuzumab deruxtecan
×
Clear all
NCT07124000
2026-06-01
DP-04
AstraZeneca
Recruiting
100 enrolled